These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1476 related items for PubMed ID: 23791950

  • 1. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K, Suzuki M, Suzuki N, Hamajo K, Tsukamoto T, Shimojo M.
    Brain Res; 2013 Aug 14; 1526():84-93. PubMed ID: 23791950
    [Abstract] [Full Text] [Related]

  • 2. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
    Suzuki N, Suzuki M, Murakami K, Hamajo K, Tsukamoto T, Shimojo M.
    Brain Res; 2012 Jan 09; 1430():93-100. PubMed ID: 22119394
    [Abstract] [Full Text] [Related]

  • 3. Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis.
    Fukuta T, Yanagida Y, Asai T, Oku N.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):873-877. PubMed ID: 29162447
    [Abstract] [Full Text] [Related]

  • 4. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.
    Exp Neurol; 2008 Jul 01; 212(1):53-62. PubMed ID: 18462720
    [Abstract] [Full Text] [Related]

  • 5. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT, Zhao JG, Li MH, Li YD.
    Brain Res; 2012 Feb 15; 1438():75-84. PubMed ID: 22227456
    [Abstract] [Full Text] [Related]

  • 6. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
    Maeda M, Furuichi Y, Ueyama N, Moriguchi A, Satoh N, Matsuoka N, Goto T, Yanagihara T.
    J Cereb Blood Flow Metab; 2002 Oct 15; 22(10):1205-11. PubMed ID: 12368659
    [Abstract] [Full Text] [Related]

  • 7. Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model.
    Suzuki N, Suzuki M, Hamajo K, Murakami K, Tsukamoto T, Shimojo M.
    PLoS One; 2012 Oct 15; 7(7):e40889. PubMed ID: 22815855
    [Abstract] [Full Text] [Related]

  • 8. Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model.
    Umemura K, Higo K, Sakata T, Yuki S, Iwata K, Yamaguchi K.
    Pathophysiol Haemost Thromb; 2008 Oct 15; 36(5):245-50. PubMed ID: 19996634
    [Abstract] [Full Text] [Related]

  • 9. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP.
    J Stroke Cerebrovasc Dis; 2016 Apr 15; 25(4):990-7. PubMed ID: 26851971
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y, Maeda M, Matsuoka N, Mutoh S, Yanagihara T.
    Exp Neurol; 2007 Mar 15; 204(1):138-46. PubMed ID: 17169359
    [Abstract] [Full Text] [Related]

  • 11. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E, Planas AM, Amaro S, Chamorro A.
    J Cereb Blood Flow Metab; 2007 Jan 15; 27(1):14-20. PubMed ID: 16596120
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
    Maeda M, Furuichi Y, Noto T, Matsuoka N, Mutoh S, Yoneda Y.
    Brain Res; 2009 Feb 13; 1254():99-108. PubMed ID: 19101526
    [Abstract] [Full Text] [Related]

  • 13. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N.
    Eur J Neurosci; 2014 Jun 13; 39(12):2107-18. PubMed ID: 24649933
    [Abstract] [Full Text] [Related]

  • 14. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M.
    Circulation; 2005 Nov 29; 112(22):3486-94. PubMed ID: 16316970
    [Abstract] [Full Text] [Related]

  • 15. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
    Maeda M, Moriguchi A, Mihara K, Aoki T, Takamatsu H, Matsuoka N, Mutoh S, Goto T.
    J Cereb Blood Flow Metab; 2005 Jan 29; 25(1):108-18. PubMed ID: 15678117
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of liposome-encapsulated hemoglobin in a rat model of cerebral ischemia.
    Kaneda S, Ishizuka T, Sekiguchi A, Morimoto K, Kasukawa H.
    Artif Organs; 2014 Aug 29; 38(8):650-5. PubMed ID: 25132081
    [Abstract] [Full Text] [Related]

  • 17. Safety of low-frequency transcranial ultrasound in permanent middle cerebral artery occlusion in spontaneously hypertensive rats.
    Wang Z, Fukuda T, Azuma T, Furuhata H.
    Cerebrovasc Dis; 2012 Aug 29; 33(1):23-9. PubMed ID: 22133698
    [Abstract] [Full Text] [Related]

  • 18. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC, Gasche Y.
    Brain Res; 2008 Dec 03; 1243():161-6. PubMed ID: 18835259
    [Abstract] [Full Text] [Related]

  • 19. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
    Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD.
    Eur J Pharmacol; 2015 Oct 05; 764():404-412. PubMed ID: 26189021
    [Abstract] [Full Text] [Related]

  • 20. Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats.
    Zhang FH, Lin YH, Huang HG, Sun JZ, Wen SQ, Lou M.
    Neuroscience; 2013 Oct 10; 250():651-7. PubMed ID: 23892005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.